Edifice Health
Latest round
- Series A
Last raised
- Apr 2021
Total raised
- $15M
Investors
- 9
About Edifice Health
Edifice Health, Inc.Founded in 2018 in San Mateo, US, Edifice Health, Inc. focuses on chronic inflammation management. The company's Inflammatory Age® test stems from a decade-long NIH-funded study at Stanford University. David Furman, the founder, has experience in health-focused ventures.Edifice Health delivers innovative solutions for monitoring and managing chronic inflammation, highlighted by its core product, the Inflammatory Age® test. This test utilizes advanced ‘omics’ technology and artificial intelligence, producing a composite biomarker score that provides insights into an individual's inflammatory and immune health.Edifice Health generates revenue by partnering with healthcare providers to offer the Inflammatory Age® testing service. This business model includes contractual agreements with clinics and physicians, facilitating comprehensive health assessments. The company plans to design and launch new products aimed at enhancing chronic disease management, with targeted expansion into new geographical markets expected by 2023.
Who invested in Edifice Health
9 investors across 2 rounds
See all investors in Edifice Health
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Edifice Health
Who invested in Edifice Health?
Edifice Health has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Edifice Health raised?
Edifice Health has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Edifice Health last raise money?
Edifice Health's most recent round on record is a Series A, in Apr 2021.
What does Edifice Health do?
Edifice Health is a biotechnology company.
Where is Edifice Health headquartered?
Edifice Health is headquartered in San Mateo, US.
Which VCs invest in companies like Edifice Health?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Edifice Health's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Edifice Health? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.